These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

807 related items for PubMed ID: 8996188

  • 21. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M, Tomomatsu N, Iwahisa Y, Yamaguchi S, Kawakami Y, Terasawa M.
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [Abstract] [Full Text] [Related]

  • 22. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
    Munoz-Cano R, Ainsua-Enrich E, Torres-Atencio I, Martin M, Sánchez-Lopez J, Bartra J, Picado C, Mullol J, Valero A.
    J Investig Allergol Clin Immunol; 2017 May; 27(3):161-168. PubMed ID: 27758758
    [Abstract] [Full Text] [Related]

  • 23. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X.
    Int J Tissue React; 1985 May; 7(5):339-43. PubMed ID: 2997065
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
    Chand N, Pillar J, Nolan K, Diamantis W, Sofia RD.
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
    [Abstract] [Full Text] [Related]

  • 25. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Alberts AW, Bugianesi RL, Chabala JC, Ponpipom MM.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
    [Abstract] [Full Text] [Related]

  • 26. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
    Kamei C, Mio M, Kitazumi K, Tsujimoto S, Yoshida T, Adachi Y, Tasaka K.
    Immunopharmacol Immunotoxicol; 1992 Aug; 14(1-2):207-18. PubMed ID: 1350791
    [Abstract] [Full Text] [Related]

  • 27. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Szalkowski DM, MacIntyre DE, Bach TJ, Luell S, Meuer R, Sahoo SP, Alberts AW, Chabala JC.
    J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
    [Abstract] [Full Text] [Related]

  • 28. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC, Seldon PM, Barnes PJ, Giembycz MA.
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [Abstract] [Full Text] [Related]

  • 29. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
    Herbert JM, Laplace MC, Maffrand JP.
    J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
    [Abstract] [Full Text] [Related]

  • 30. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
    Balsa D, Merlos M, Giral M, Ferrando R, Garcia-Rafanell J, Forn J.
    Drugs Exp Clin Res; 1997 Feb; 23(5-6):191-9. PubMed ID: 9515229
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T, Saito M, Mase T, Hara H, Nagaoka H, Murase K, Tomioka K.
    Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
    [Abstract] [Full Text] [Related]

  • 32. Rupatadine in allergic rhinitis and chronic urticaria.
    Mullol J, Bousquet J, Bachert C, Canonica WG, Gimenez-Arnau A, Kowalski ML, Martí-Guadaño E, Maurer M, Picado C, Scadding G, Van Cauwenberge P.
    Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
    [Abstract] [Full Text] [Related]

  • 33. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C, Rousselot C, Chavernac G, Depin JC, Guerrier D.
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [Abstract] [Full Text] [Related]

  • 34. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J, Schoemaker H, Dana C, Claustre Y, Delahaye M, Prouteau M, Manoury P, Allen J, Scatton B, Langer SZ.
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [Abstract] [Full Text] [Related]

  • 35. Histamine release from rabbit platelets by platelet-activating factor (PAF).
    Nakahodo K, Saitoh S, Nakamura M, Kosugi T.
    Arerugi; 1994 Mar; 43(3):501-10. PubMed ID: 7515227
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.
    Wu MS, Biftu T, Doebber TW.
    J Pharmacol Exp Ther; 1986 Dec; 239(3):841-5. PubMed ID: 3795043
    [Abstract] [Full Text] [Related]

  • 37. Sch 37370: a new drug combining antagonism of platelet-activating factor (PAF) with antagonism of histamine.
    Billah MM, Chapman RW, Watnick AS, Egan RW, Siegel MI, Kreutner W.
    Agents Actions Suppl; 1991 Dec; 34():313-21. PubMed ID: 1793070
    [Abstract] [Full Text] [Related]

  • 38. UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo.
    Alabaster VA, Keir RF, Parry MJ, de Souza RN.
    Agents Actions Suppl; 1991 Dec; 34():221-7. PubMed ID: 1793066
    [Abstract] [Full Text] [Related]

  • 39. Protective effect of SR 27417, a novel PAF antagonist, on PAF- or endotoxin-induced hypotension in the rat and the guinea-pig.
    Bernat A, Herbert JM, Salel V, Lespy L, Maffrand JP.
    J Lipid Mediat; 1992 Feb; 5(1):41-8. PubMed ID: 1391738
    [Abstract] [Full Text] [Related]

  • 40. Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents.
    Lv XX, Wang XX, Li K, Wang ZY, Li Z, Lv Q, Fu XM, Hu ZW.
    PLoS One; 2013 Feb; 8(7):e68631. PubMed ID: 23869224
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.